Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal
Selma Ugurel

Showing results (101-110 of 490) with videos related to

Pageof 49
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2014
Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient--letterMathias Bernhardt, Elias Orouji, Lionel Larribere, et al.
Cancer Treatment Reviews|June 7, 2021
NRAS mutant melanoma: Towards better therapiesTijana Randic, Ines Kozar, Christiane Margue, et al.
Seminars in Cancer Biology|July 21, 2015
Function and significance of MicroRNAs in benign and malignant human stem cellsJochen Utikal, Mohammed Abba, Daniel Novak, et al.
Acta Dermato-Venereologica|April 9, 2014
Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenibChristoffer Gebhardt, Janina Staub, Astrid Schmieder, et al.
Medicine|December 20, 2014
Leukocyte count restoration under dabrafenib treatment in a melanoma patient with vemurafenib-induced leukopenia: case reportElias Orouji, Birgit Ziegler, Viktor Umansky, et al.
International Journal of Molecular Sciences|July 2, 2021
Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies?Fabrice Tolle, Viktor Umansky, Jochen Utikal, et al.
International Journal of Cancer|June 16, 2005
Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanomaSelma Ugurel, Nellie Bell, Antje Sucker, et al.
Deutsches Arzteblatt International|March 16, 2012
Cutaneous side effects of new antitumor drugs: clinical features and managementRalf Gutzmer, Andreas Wollenberg, Selma Ugurel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 23, 2009
Cutaneous metastases as the first clinical sign of metastatic gastric carcinomaLidia Frey, Claudia Vetter-Kauczok, Anja Gesierich, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 5, 2009
Therapy of metastasized Merkel cell carcinoma with liposomal doxorubicin in combination with radiotherapyMarion Wobser, Natalie Kürzinger, Selma Ugurel, et al.
Pageof 49

Showing results (101-110 of 490) with videos related to

Sort By:
Pageof 49
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2014
Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient--letterMathias Bernhardt, Elias Orouji, Lionel Larribere, et al.
Cancer Treatment Reviews|June 7, 2021
NRAS mutant melanoma: Towards better therapiesTijana Randic, Ines Kozar, Christiane Margue, et al.
Seminars in Cancer Biology|July 21, 2015
Function and significance of MicroRNAs in benign and malignant human stem cellsJochen Utikal, Mohammed Abba, Daniel Novak, et al.
Acta Dermato-Venereologica|April 9, 2014
Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenibChristoffer Gebhardt, Janina Staub, Astrid Schmieder, et al.
Medicine|December 20, 2014
Leukocyte count restoration under dabrafenib treatment in a melanoma patient with vemurafenib-induced leukopenia: case reportElias Orouji, Birgit Ziegler, Viktor Umansky, et al.
International Journal of Molecular Sciences|July 2, 2021
Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies?Fabrice Tolle, Viktor Umansky, Jochen Utikal, et al.
International Journal of Cancer|June 16, 2005
Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanomaSelma Ugurel, Nellie Bell, Antje Sucker, et al.
Deutsches Arzteblatt International|March 16, 2012
Cutaneous side effects of new antitumor drugs: clinical features and managementRalf Gutzmer, Andreas Wollenberg, Selma Ugurel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 23, 2009
Cutaneous metastases as the first clinical sign of metastatic gastric carcinomaLidia Frey, Claudia Vetter-Kauczok, Anja Gesierich, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 5, 2009
Therapy of metastasized Merkel cell carcinoma with liposomal doxorubicin in combination with radiotherapyMarion Wobser, Natalie Kürzinger, Selma Ugurel, et al.
Pageof 49